White Paper: The International Receptor Tyrosine Kinase Networks Consortium

Biology is undergoing a fundamental shift from a descriptive to a quantitative, and ultimately, predictive science.

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Editor's Note: In February, The Scientist's Richard Gallagher editorialized that we would soon be publishing "the manifesto of [a] bottom-up, big science group:"1

"It will be organized around the traditional approach of small, independent research teams chipping away at pet problems. Science will remain a personal pursuit, with scientists maintaining control of their own research. But the team's efforts will be integrated and designed as a virtuous circle of modeling of the system driving experiments that will in turn tune the model, generating more experiments."

The purpose, he wrote, would "be important contributions to a broader agenda, bringing a fuller understanding to a complex and vital area of biology. At least as important will be what I anticipate is the proof of principle of this important strategy." We are pleased to present the white paper of that group, the International Receptor Tyrosine Kinase Networks Consortium.

Courtesy RTK Consortium

Biology is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies